Skip to Content

View Additional Section Content

An Open-Label, Phase 2 Basket Study of Neratinib in Patients With Solid Tumors With Somatic Activating HER Mutations

For more information on this trial, click the link below.

https://clinicaltrials.gov/ct2/show/NCT01953926

Clinical Trial Categories

  • Solid Tumors
Contact
Ashley Douglas, RN at 215-481-4429

Location

  • Asplundh Cancer Pavilion
    3941 Commerce Ave.
    Willow Grove, PA 19090

Find a Physician
Search Our Directory

215-481-MEDI
215-481-6334

Schedule a
Test

215-481-EXAM
215-481-3926